Jessica Villafana
Nurse Practitioner · Bakersfield, CANPI 1063177673
Payments from drug & device makers
Across 232 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$806
- Incyte Corporation$386
- E.r. Squibb & Sons, L.L.C.$334
- Arcutis Biotherapeutics, Inc.$290
- Strata Skin Sciences, Inc.$242
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,13895%
- Education$2955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,034 |
| Johnson & Johnson | 28 | $806 |
| Incyte Corporation | 17 | $386 |
| E.r. Squibb & Sons, L.L.C. | 13 | $334 |
| Arcutis Biotherapeutics, Inc. | 15 | $290 |
| Strata Skin Sciences, Inc. | 3 | $242 |
| Sun Pharmaceutical Industries Inc. | 11 | $209 |
| Daiichi Sankyo Inc. | 5 | $176 |
| Lilly USA, LLC | 7 | $166 |
| Amgen | 9 | $160 |
| Sanofi | 5 | $157 |
| UCB, Inc. | 6 | $152 |
| Nevro Corp. | 1 | $147 |
| AstraZeneca | 2 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
| Sobi, Inc | 5 | $115 |
| Blueprint Medicines Corporation | 3 | $82 |
| Organogenesis Inc. | 5 | $80 |
| Smith+Nephew | 2 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $69 |
| Biofrontera Inc. | 3 | $57 |
| Stemline Therapeutics Inc. | 2 | $56 |
| Novartis | 3 | $52 |
| LEO Pharma Inc. | 2 | $43 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Geron Corporation | 1 | $31 |
| Genmab U.S., Inc. | 1 | $29 |
| Bristol Myers Squibb | 1 | $28 |
| Botanix SB Inc | 1 | $28 |
| Eisai Inc. | 1 | $25 |
| GSK | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Organon | 1 | $21 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,433 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 14 | $623 |
| Ketoconazole | 18 | $210 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bakersfield
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.